Leif G Salford, chairman of the scientific advisory board
Leif G. Salford is one of the founders of Idogen, senior professor of neurosurgery and director of the Rausing laboratory for translational neurooncology at Lund University. His scientific work combines immune- and gene therapy for the most malignant brain tumors and he has also been widely recognized for his work on the effect of electromagnetic radiation on the blood-brain barrier. Professor Salford has conducted research in neurosurgery at Lund University, University of Gothenburg, Kuwait University and Cornell Medical Centre in New York. He has had several important assignments, such as chief medical officer at the Sahlgrenska hospital, divisional manager and board member of the Lund University Hospital board, head of the department of Clinical Sciences, Lund University and has been Chairman of the World federation of neurosurgical societies (WFNS) committee on neurooncology and President of the European association for neurooncology (EANO).